ID 原文 译文
1272 2~7μg/mL 2~7 μg/mL
1273 谷浓度与骨髓抑制不良反应相关，需密切监测血三系水平。 The trough concentration correlates with myelosuppression adverse reactions. The blood routine test needs to be closely monitored.
1275 当日给药前30min内 30 min before the drug administration
1276 1~5.5μg/mL 1~5.5 μg/mL
1277 谷浓度与疗效和肝功能受损等不良反应相关 The trough concentration correlates with the therapeutic efficacy and adverse reactions such as impaired liver function.
1278 注意潜在的药物相互作用 Paying attention to the potential drug interactions
1279 由于抗病毒药物如洛匹那韦/利托那韦经肝脏CYP3A酶代谢，如有多重用药时须仔细排查可能的药物相互作用，合理选择药物。 Antiviral drugs such as lopinavir/ritonavir are metabolized through the enzyme CYP3A in the liver. When patients receiving concomitant medications, the potential drug interactions need to be carefully screened.
1280 有关抗病毒药物与常见基础疾病用药的相互作用见表2。 Table 2 shows interactions bet ween antiviral drugs and common drugs for underlying diseases.
1281 表2 抗病毒药物与常见基础疾病用药的相互作用 Table 2 Interactions bet ween antiviral drugs and common drugs for underlying
1282 药品名称 Drug names